| What's New Online! |
The Evolving Paradigm of Molecular-Based Diagnosis and Targeted Therapies in Breast Cancer
|
|
Click here to enter the activity
- Discussing Systemic Adjuvant Therapy With Patients and Colleagues: A Surgeon’s Perspective
- Optimizing Tissue Handling and Interpretation of Protein- and Gene-Based Assays
- Review of Results From HER2-Targeted Adjuvant Therapy: How Have We Affected Patient Outcomes?
- Preoperative Systemic Therapy for HER2-Positive Breast Cancer: What Have We Learned?
|
Management of Platinum-Sensitive Recurrent Ovarian Cancer
March 29, 2008
New York, NY |
|
|
|
Click here to enter the activity
- Practical Issues in the Management of Platinum-Sensitive Recurrent Ovarian Cancer
- Platinum-Based Treatment Options in Recurrent Ovarian Cancer
- Other Major Issues in Treating Platinum-Sensitive Recurrent Ovarian Cancer
|
Fifth International Symposium on Ovarian Cancer and Gynecologic Malignancies
March 28-29, 2008
New York, NY |
|
|
|
Click here to enter the activity
- Debates on Ovarian Cancer
- Controversial Roles for Surgery
- New Agents and Translational Research in Ovarian Cancer
- Debates on Endometrial Cancer
- Optimal Systemic Therapy for Advanced Uterine Cancer
- New Agents and Translational Research in Cervical and Uterine Cancers
|
Patient Communication: The Surgeon’s Role
March 15 , 2008
Chicago, IL |
|
|
|
Click here to enter the activity
- Explaining Tissue Biomarkers to Patients
- Reviewing Individualized Benefits and Side Effects of Systemic Therapy
- Communicating the Promises and Limitations of Targeted Therapy
- The Impact of Advocacy in Cancer Care and Research
- The Surgeon’s Role in Charting the Course of Postoperative Therapy
1.25 AMA PRA Category 1 Credits™
Expiration date: March 31, 2009 |
| |
Current Trends in Leukemia, Lymphoma, and Myeloma
March 7, 2008
Chicago, IL |
|
|
|
Click here to enter the activity
- Non-Hodgkin Lymphoma
- Myelodysplastic Syndromes and Acute Leukemias
- Plasma Cell Malignancies
- Chronic Leukemias
- Benign Hematologic Disorders and Supportive Care
|
| |
Current Trends in Lung and Head & Neck Cancers
March 7, 2008
Atlanta, GA |
|
|
|
Click here to enter the activity
- Adjuvant Therapy for NSCLC: Where Are We in 2008?
- Combined-Modality Therapy for Stage III NSCLC
- State of the Art in Advanced NSCLC
- What’s New With Angiogenesis Inhibitors in NSCLC?
- Recent Developments With EGFR Inhibition
- Pharmacogenomic Customization of Lung Cancer Therapy
- Novel Agents in Development for NSCLC
- Head and Neck Cancer: Current Clinical Data in 2008
- 2008 Controversies in Head and Neck Cancer
|
| |
